Mechanistically, it has been shown that PrPM129V polymorphisms modulate BACE (β secretase) cleavage of APP and thus affect levels of Aβ42 associated with increased Alzheimer Disease risk [38], [71]–[73]. This evidence concerns the gene APP and Alzheimer disease.